This chapter provides an introduction and overview of important issues that served as motivations for this book. For many complex phenotypes (e.g., depression, diabetes, obesity, substance use), there is substantial evidence that while genetic influences are important, so are environmental influences; moreover, there is substantial evidence from both behavior genetic studies (e.g., twin and adoptee studies) and molecular genetic studies (both human and infrahuman) that genes commonly interact with environmental factors in predicting complex phenotypes. The fields of genomics and other –omics (e.g., proteomics, metabolomics) provide exciting opportunities to advance science and foster the goals of public health and a more individualized intervention approach (e.g., precision medicine). The goals of these more individualized approaches would benefit greatly not only by advances in genomics and other –omics, but also by incorporating information both on environments and their interactions with genomic and other biological material and regulatory processes (e.g., environmental signal to biological pathway responses). Such findings would thereby offer more flexible guidance to a broader range of prevention, intervention, and treatment targets, and facilitate more tailored programs based on a fuller complement of G and E influences.
A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase
